Delivery Order SPE2DB20D1100-SPE2DB24FD6W4
Award Date
9/6/24
Potential Completion Date
9/9/24
Potential Value
$45K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $1,046.80 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is to provide the medication Bydureon BCISE 2 mg autoinjector 0.85 mL. The award has an ultimate completion date of February 22, 2024. AmerisourceBergen, a for-profit organization registered in the System for Award Management, holds a $999,999,999 Indefinite Delivery Contract with the DLA Troop...
This is a $5,442.78 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a prescription medication, with a completion date of September 5, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the DLA to efficiently procure a...
This is a $16,626.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The delivery order is for the supply of Bydureon Bcise 2 mg autoinjectors, which are used to treat type 2 diabetes. The contract has an ultimate completion date of September 9, 2024. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
This $7,291.04 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML. The order was placed under Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical supplier, for the provision of 4,564,312,600 units of the medication Bydureon BCISE 2 mg AutoInject 0.85 mL. The contract has a ceiling value of $4,270.80 and a period of performance ending on April 18, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to...
This is a $14,568.42 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, which are pharmaceutical products used to treat certain medical conditions. This order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector medication. The contract has a ceiling value of $5,436.04 and a period of performance through July 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999...
This is a $7,447.05 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML, a medication used in the treatment of diabetes. The contract has an ultimate completion date of January 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order for $15,369.06 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medication. This delivery order is part of an indefinite delivery contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to support military treatment programs worldwide. The...
This federal contract award is a delivery order from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,469,511 units of the Bydureon BCISE 2 mg auto-injector medication. The $13,934.59 firm-fixed-price contract has an ultimate completion date of August 16, 2024. The award is not associated with a set-aside program. As a large pharmaceutical supplier, Amerisourcebergen has been awarded numerous federal contracts, including a...